REMS Take Effect; FDA Identifies 16 Products With RiskMAPs That Qualify

Manufacturers of approved products whose marketing conditions qualify for a Risk Evaluation and Mitigation Strategy will have to develop a timeline for the assessment of their risk management efforts by September 21